HOOKIPA Pharma Inc.

NASDAQ: HOOK · Real-Time Price · USD
0.83
-0.01 (-1.19%)
At close: Aug 15, 2025, 1:55 PM
0.83
0.00%
After-hours: Aug 15, 2025, 01:55 PM EDT

HOOKIPA Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
9.35M 43.95M 50M 52.16M 53.55M 20.13M 20.55M 15.91M 15.98M 14.25M 10.32M 11.96M 14.59M 18.45M 19.72M 19.88M 21.19M
Cost of Revenue
699K 699K 1.28M 1.76M 2.63M 3.55M 3.18M 3.45M 3.44M 3.6M 3.93M 23.86M 42.58M 61.66M 73.9M 69.21M 61.2M
Gross Profit
8.65M 43.25M 48.72M 50.4M 50.92M 16.58M 17.37M 12.46M 12.54M 10.65M 6.39M -11.9M -27.98M -43.21M -54.18M -49.33M -40.01M
Operating Income
-80.44M -51.45M -48.13M -52.15M -51.16M -84.93M -80.39M -78.71M -75.67M -73.16M -81.61M -81.79M -82.65M -81.67M -74.82M -70.06M -60M
Interest Income
2.61M 3.7M 4.45M 5.21M 5.45M 5.29M 4.96M 3.93M 2.8M 1.63M 730K 202K 27K 27K 30K 43K 95K
Pretax Income
-73.42M -43.61M -43.21M -48.43M -47.35M -81.42M -69.07M -68.29M -66.63M -64.91M -73.84M -75.6M -76.39M -75.67M -66.91M -60.45M -50.39M
Net Income
-73.31M -43.5M -43.37M -48.6M -47.52M -81.58M -69.07M -68.29M -66.63M -64.92M -73.84M -75.6M -76.4M -75.67M -66.91M -60.45M -50.39M
Selling & General & Admin
23.06M 20.23M 17.83M 16.01M 16.51M 17.36M 18.08M 18.11M 18.69M 18.76M 18.46M 17.86M 17.93M 17.27M 18.41M 18.51M 17.76M
Research & Development
61.2M 68.51M 76.64M 85.7M 85.66M 86.42M 82.85M 76.52M 72.96M 68.64M 73.47M 75.88M 79.31M 82.85M 76.12M 71.43M 63.42M
Other Expenses
5.53M 6.67M 2.37M 490K 461K -1.03M -2.31M -3.56M -5.54M -7.21M -7.42M -6.47M -4.67M -2.84M 108K 2.23M 3.04M
Operating Expenses
89.79M 95.4M 96.85M 103.04M 101.22M 101.56M 98.72M 90.33M 87.61M 81.48M 86M 87.42M 90.36M 92.93M 87.34M 83.24M 75.39M
Interest Expense
n/a 2K 51K 100K 197K 317K 376K 432K 566K 687K 806K 935K 922K 898K 870K 830K 778K
Selling & Marketing Expenses
n/a n/a -1.28M -1.28M -1.28M -1.28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
85.49M 91.11M 98.12M 104.31M 102.5M 102.84M 98.72M 90.33M 87.61M 81.48M 86M 87.42M 90.36M 92.93M 87.34M 83.24M 75.39M
Income Tax Expense
-106K -106K 164K 164K 286K 491K 556K 556K 435K 230K -1K n/a 59K 220K -3.67M -3.67M -3.73M
Shares Outstanding (Basic)
12.54M 12.05M 12.54M 12.54M 13.08M 11.28M 11.04M 8.26M 7.22M 7.24M 7.22M 7.22M 4.5M 3.27M 3.29M 3.28M 3.28M
Shares Outstanding (Diluted)
12.54M 12.05M 12.54M 12.54M 12.6M 11.28M 11.04M 8.27M 7.22M 7.24M 7.22M 7.22M 4.5M 3.27M 3.29M 3.28M 3.28M
EPS (Basic)
-5.84 -3.46 -3.67 -4.3 -4.96 -8.84 -8.34 -9.14 -9.23 -10.49 -15.29 -18.86 -21.82 -23.09 -21.21 -20.41 -17.95
EPS (Diluted)
-5.84 -3.51 -3.72 -4.35 -5.01 -8.84 -8.34 -9.14 -9.23 -10.49 -15.29 -18.86 -21.82 -23.09 -21.19 -20.39 -17.93
EBITDA
-70.92M -40.85M -39.82M -45.21M -43.88M -77.34M -65.08M -63.97M -62.18M -60.4M -69.11M -70.41M -70.86M -70.13M -59.99M -54.04M -44.77M
EBIT
-73.42M -43.61M -43.16M -48.33M -47.16M -80.89M -68.26M -67.42M -65.63M -64M -73.03M -74.66M -75.47M -74.77M -66.03M -59.62M -49.62M
Depreciation & Amortization
2.5M 2.75M 3.33M 3.12M 3.27M 3.55M 3.18M 3.45M 3.44M 3.6M 3.93M 4.26M 4.62M 4.64M 6.04M 6.11M 5.86M